3151 - 3160 of 4301 Drugs
Lovaza (omega-3-acid ethyl esters)
Lovaza (omega-3-acid ethyl esters) is a combination of fatty acids used together with diet and exercise to help lower triglyceride levels in the blood. Lovaza is made of omega-3 polyunsaturated fatty acids, which are found in oil from fish, vegetables, and other plant sources. These fatty acids are not made by the body and must be consumed in the diet.
Low-Ogestrel (norgestrel and ethinyl estradiol tablets)
Low-Ogestrel (norgestrel and ethinyl estradiol tablets) is a combination of female hormones used as contraception to prevent pregnancy. Low-Ogestrel is available in generic form.
Loxapine (loxapine succinate)
Loxapine (loxapine succinate) Capsule is an antipsychotic medication used to treat schizophrenia. Loxapine is available in generic form.
Loxitane (loxapine)
Loxitane (loxapine succinate) Capsule is an antipsychotic medication used to treat schizophrenia. Loxitane is available in generic form.
Lucentis (ranibizumab injection)
Lucentis (ranibizumab) Injection is a monoclonal antibody that works by slowing the growth of abnormal new blood vessels in the eye and decreasing leakage from these blood vessels used to treat the wet form of age-related macular degeneration.
Surfaxin (lucinactant intratracheal suspension)
Surfaxin (lucinactant) is a surfactant indicated for the prevention of respiratory distress syndrome (RDS), a breathing disorder that affects premature infants.
Luzu (luliconazole cream, 1%)
Luzu (luliconazole) Cream, 1% is an azole antifungal agent used indicated to topically treat interdigital tinea pedis (athlete's foot), tinea cruris (jock itch), and tinea corporis (ringworm of the body) caused by the organisms Trichophyton rubrum and Epidermophyton floccosum.
Orkambi (lumacaftor and ivacaftor film-coated tablets for oral administration)
Orkambi (lumacaftor/ivacaftor) is a combination of cystic fibrosis transmembrane conductance regulator (CFTR) potentiators indicated for the treatment of cystic fibrosis (CF) in patients age 12 years and older who are homozygous for the F508del mutation in the CFTR gene.
Oxlumo (lumasiran injection)
Oxlumo (lumasiran) is a HAO1-directed small interfering ribonucleic acid (siRNA) used to treat primary hyperoxaluria type1 (PH1) to lower urinary oxalate levels in pediatric and adult patients.